McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
866.03
+16.57 (1.95%)
At close: Nov 21, 2025, 4:00 PM EST
867.20
+1.17 (0.14%)
After-hours: Nov 21, 2025, 7:57 PM EST
McKesson Revenue
McKesson had revenue of $103.15B in the quarter ending September 30, 2025, with 10.14% growth. This brings the company's revenue in the last twelve months to $387.09B, up 17.23% year-over-year. In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth.
Revenue (ttm)
$387.09B
Revenue Growth
+17.23%
P/S Ratio
0.28
Revenue / Employee
$7,590,078
Employees
51,000
Market Cap
106.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
MCK News
- 6 days ago - Our Top 10 High Growth Dividend Stocks - November 2025 - Seeking Alpha
- 11 days ago - McKesson Corporation (MCK) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 16 days ago - McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 16 days ago - McKesson raises annual profit forecast on robust demand for specialty drugs - Reuters
- 16 days ago - McKesson Corporation Reports Fiscal 2026 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire
- 22 days ago - McKesson Corporation Declares Quarterly Dividend - Business Wire
- 5 weeks ago - Nike and 3 More Companies Raising the Alarm About Tariff Costs - Barrons
- 5 weeks ago - The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage. - Barrons